Magnetic resonance spectroscopy: a powerful tool for drug metabolism studies.
Studies on the metabolism and disposition of drugs using nuclear magnetic resonance spectroscopy (MRS) as the analytical technique are reviewed. An overview of the main studies classed in terms of the observed magnetic nucleus (1H, 2H, 7Li, 13C, 19F, 31P, 77Se) is followed by some typical examples of the way in which 19F and 31P MRS can be profitably employed to gain more understanding about the metabolism and disposition of the anticancer fluoropyrimidines (5-fluorouracil (FU) and its prodrugs) and ifosfamide (IF). The results of three recent studies carried out in our laboratory are developed. They concern the direct quantitative monitoring of the hepatic metabolism of FU in the isolated perfused mouse liver, the elucidation of the origin of the cardiotoxicity of FU and the metabolism of IF from an analysis of biofluids of patients. Finally, the advantages and limitations of MRS for investigations on drug metabolism are discussed.
Malet-Martino
M C
MC
Laboratoire des IMRCP, URA CNRS 470, Université Paul Sabatier, Toulouse, France.
Martino
R
R
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism; D005461:Fluorine; D006801:Humans; D007069:Ifosfamide / Q000378:metabolism; D007554:Isotopes; D009682:Magnetic Resonance Spectroscopy; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010758:Phosphorus; D011743:Pyrimidines / Q000378:metabolism
D000970:Antineoplastic Agents; D007554:Isotopes; D004364:Pharmaceutical Preparations; D011743:Pyrimidines; D010758:Phosphorus; D005461:Fluorine; D007069:Ifosfamide